CIAM
SER icon

Caitong International Asset Management’s Serina Therapeutics SER Stock Holding History

Caitong International Asset Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.72K Buy
+3,982
New +$8.77K ﹤0.01% 1103

Other funds holding SER

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's SER Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Serina Therapeutics (SER) in Q1 2026: 3,982 shares worth $7.72K. The stake represents ﹤0.01% of the portfolio and ranks #1103 among its holdings.

25 funds tracked by Wall St. Rank hold SER as of Q1 2026.

  • Caitong International Asset Management held 3,982 shares of Serina Therapeutics worth $7.72K as of Q1 2026.
  • Serina Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Serina Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1103 holding.
  • 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.